| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/12/2003 | CN1101182C Sustained release and implantation type antineoplasma medicine and method for preparing same |
| 02/12/2003 | CN1101181C Haemorrhoidal compositions and method of use |
| 02/12/2003 | CN1101180C Cosmetics and/or composition for treating skin disease and use thereof |
| 02/12/2003 | CN1101146C Method for suppressing bitter taste |
| 02/11/2003 | WO2002092057A1 Tablets quickly disintegrating in the oral cavity and process for producing the same |
| 02/11/2003 | US6518397 Pharmaceuticals for modulating hormone responsiveness |
| 02/11/2003 | US6518269 Cancer treatment |
| 02/11/2003 | US6518252 Method of treating aquatic animals with an antimicrobial agent and chelating agent |
| 02/11/2003 | US6518239 Dry powder compositions having improved dispersivity |
| 02/11/2003 | US6517887 Method and a device for coating a tablet, a capsule, a pill or the like |
| 02/11/2003 | US6517886 Uncooked, unspun food comprised of saccharide, humectant and fat; sufficient internal cohesiveness to be handled without losing integrity; soft yet unsticky chew texture |
| 02/11/2003 | US6517883 Satiety product |
| 02/11/2003 | US6517871 Amorphous ammonium salt; blocking angiotensin II receptors; treating hypertension, congestive heart failure and renal failure |
| 02/11/2003 | US6517870 Improved taste by reducing bitterness and saltiness |
| 02/11/2003 | US6517869 Coupling such as DNA, RNA, oligonucleotides, proteins, peptides or drugs to free amino group |
| 02/11/2003 | US6517868 Amino acid modulated extended release dosage form |
| 02/11/2003 | US6517867 Dry mix formulation for bisphosphonic acids |
| 02/11/2003 | US6517866 Sertraline salts and sustained-release dosage forms of sertraline |
| 02/11/2003 | US6517865 Water soluble cellulose ethers, hydrocolloides and sequestering agents. |
| 02/11/2003 | US6517864 Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder |
| 02/11/2003 | US6517860 Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery |
| 02/11/2003 | US6517859 Injectable, drug delivery vehicles; controlled release of bioactive agents to sites within the central nervous system; dopamine, cholecystokinin, and epidermal and basic fibroblast growth factors for Parkinson's disease |
| 02/11/2003 | US6517854 Antimicrobial sanitizing lotion with skin protection properties |
| 02/11/2003 | US6517853 Dispersing a melt, cooling below melting point and ultra-sonically crystallizing from an oil in water emulsion |
| 02/11/2003 | US6517848 Method for sequestration of skin irritants with absorbent article composition |
| 02/11/2003 | US6517847 Topical gel delivery system |
| 02/11/2003 | US6517809 Using a breath test; vehicle containing a sugar is powder or granules, coating vehicle with an isotope-labeled urea and encapsulating the coated vehicle in gelatin |
| 02/11/2003 | US6517808 Boron neutron capture therapy used to destroy tumors; carboranes encapsulated in liposomes; |
| 02/11/2003 | CA2320129C Suspension aerosol formulations |
| 02/11/2003 | CA2181502C Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract |
| 02/11/2003 | CA2176223C Fenbendazole formulations |
| 02/11/2003 | CA2156905C Powdery pharmaceutical preparation and method of manufacturing same |
| 02/11/2003 | CA2110376C Pharmaceutical enema preparation |
| 02/11/2003 | CA2070877C Re-formulated diamox sustets |
| 02/08/2003 | CA2354932A1 Topical treatment of pain and to promote healing |
| 02/06/2003 | WO2003010298A1 'probiotic lactobacillus salivarius strains |
| 02/06/2003 | WO2003010297A1 Probiotic bifidobacterium strains |
| 02/06/2003 | WO2003010188A1 Production of high molecular mass lectins |
| 02/06/2003 | WO2003010182A1 Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same |
| 02/06/2003 | WO2003010173A1 Stabilized derivatives of ascorbic acid -3-phosphate |
| 02/06/2003 | WO2003009881A2 Novel targeted delivery system for bioactive agents |
| 02/06/2003 | WO2003009877A1 Topical pharmaceutical formulation |
| 02/06/2003 | WO2003009873A2 Use of pulmonary surfactant as humectant |
| 02/06/2003 | WO2003009868A1 Antigenic compositions |
| 02/06/2003 | WO2003009846A1 Novel substituted benzimidazole dosage forms and method of using same |
| 02/06/2003 | WO2003009842A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 02/06/2003 | WO2003009841A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 02/06/2003 | WO2003009834A1 Oral delivery of pharmaceuticals via encapsulation |
| 02/06/2003 | WO2003009833A1 Sustained release delivery system |
| 02/06/2003 | WO2003009832A1 Non-gelatin based capsules |
| 02/06/2003 | WO2003009831A1 Compositions containing sustained-release fine grains for tablets quickly disintegrable in the oral cavity and process for producing the same |
| 02/06/2003 | WO2003009830A1 Coated granules of allylamine- or benzylamine-anti-mycotics |
| 02/06/2003 | WO2003009829A2 Antiemetic, anti-motion sustained release drug delivery system |
| 02/06/2003 | WO2003009828A1 Modifying the fatty acid composition of cell membranes of organs and tissues |
| 02/06/2003 | WO2003009817A2 Stable lyophilized pharmaceutical formulation of igg antibodies |
| 02/06/2003 | WO2003009800A1 Sustained-release therapeutic bioadhesive systems |
| 02/06/2003 | WO2003009784A1 Ophthalmic drug delivery device |
| 02/06/2003 | WO2003009741A2 Methods for treating joint inflammation, pain, and loss of mobility |
| 02/06/2003 | WO2002096433A9 Methods for treating delirium using glucocorticoid receptor-specific antagonists |
| 02/06/2003 | WO2002096423A3 Combination of a pde4 inhibitor and tiotropium or derivate thereof for treating obstructive airways |
| 02/06/2003 | WO2002089773A3 Pharmaceutical compositions comprising cyclosporin |
| 02/06/2003 | WO2002085951A3 Water soluble, randomly substituted partial n-, partial o-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof |
| 02/06/2003 | WO2002085337B1 Micellar drug delivery systems for hydrophobic drugs |
| 02/06/2003 | WO2002078605A3 Premixed amiodarone parenteral solution and method for making the same |
| 02/06/2003 | WO2002064112A3 Therapeutic agents complexed with calcium phosphate and encased by casein |
| 02/06/2003 | WO2002060950A3 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 02/06/2003 | WO2002060424A3 Methods of using and compositions comprising sibutramine metabolites optionally in combination with other pharmacologically active compounds |
| 02/06/2003 | WO2002055060A3 Skin product having micro-spheres, and processes for the production thereof |
| 02/06/2003 | WO2002045779A3 Patient activated administration of drug bolus from implantable drug delivery system having timer for lockout interval |
| 02/06/2003 | WO2002045769A9 A bilayer structure which encapsulates multiple containment units and uses thereof |
| 02/06/2003 | WO2002032871A3 Compounds and methods for treating multidrug resistance |
| 02/06/2003 | WO2002032396A3 Lipid-protein-sugar particles for delivery of nucleic acids |
| 02/06/2003 | WO2002013870A3 Formulation for administering therapeutic lipophilic molecules |
| 02/06/2003 | WO2002002645A8 COLD WATER SOLUBLE β-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME |
| 02/06/2003 | WO2001091725A9 Biologically useful polyphosphates |
| 02/06/2003 | US20030028256 Prosthetic foot with tunable performance |
| 02/06/2003 | US20030028184 Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods |
| 02/06/2003 | US20030028170 Controlled dosage drug delivery |
| 02/06/2003 | US20030028080 Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods |
| 02/06/2003 | US20030028079 Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods |
| 02/06/2003 | US20030028000 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferative disorders |
| 02/06/2003 | US20030027983 Transport protein for use in the treatment of blood, hypertensive and epileptic disorders |
| 02/06/2003 | US20030027868 Aminoacetalization of camphor by reacting with NH4OH and suspending product in NaCl; preparation having a basic pH is then neutralised with nitric acid; product is an analogue of human cytokines |
| 02/06/2003 | US20030027858 Emulsion vehicle for poorly soluble drugs |
| 02/06/2003 | US20030027856 Tolterodine metabolites |
| 02/06/2003 | US20030027848 Stabilized formulations |
| 02/06/2003 | US20030027841 Percutaneously applicable preparation and suppository containing an antidementia medicament |
| 02/06/2003 | US20030027833 Compositions and delivery systems for administration of a local anesthetic agent |
| 02/06/2003 | US20030027818 Treatment of cancers |
| 02/06/2003 | US20030027816 Oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate salt or solvate; useful for treatment of psychotic patients |
| 02/06/2003 | US20030027811 Compositions containing alpha-2-adrenergic agonist components |
| 02/06/2003 | US20030027804 Administering to the mammal a menopause disorder effective amount of an orally deliverable pharmaceutically- acceptable sex hormone binding globulin synthesis inhibiting agent, and at least one of a non-orally deliverable steroids |
| 02/06/2003 | US20030027793 Transdermal treatment of parkinson's disease |
| 02/06/2003 | US20030027791 Composition and method for reducing adverse interactions between phenothiazine derivatives and plasma using cyclodextrins |
| 02/06/2003 | US20030027790 Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems |
| 02/06/2003 | US20030027786 Lipase inhibiting composition |
| 02/06/2003 | US20030027785 Administering to a subject a purinergic receptor agonist in an amount therapeutically effective to alter the amount or formulation of synovial fluids |
| 02/06/2003 | US20030027782 Method for treating allergic lung disease |
| 02/06/2003 | US20030027780 For transporting therapeutic, prophylactic and diagnostic agents across mucosal membranes such as gastrointestinal, buccal, nasal, rectal and vaginal |
| 02/06/2003 | US20030027772 Composition containing at least one inhibitor of the enzyme 3-beta-HSD |